𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study

✍ Scribed by Zhou, C. C.; Bai, C. X.; Guan, Z. Z.; Jiang, G. L.; Shi, Y. K.; Wang, M. Z.; Wu, Y. L.; Zhang, Y. P.; Zhu, Y. Z.


Book ID
125378126
Publisher
Springer Milan
Year
2013
Tongue
Spanish
Weight
170 KB
Volume
16
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES